Yan X - Search Results

1

Twelve-year experience with laparoscopic radical hysterectomy and pelvic lymphadenectomy in cervical cancer.

Yan X, Li G, Shang H, Wang G, Han Y, Lin T, Zheng F. Yan X, et al. Gynecol Oncol. 2011 Mar;120(3):362-7. doi: 10.1016/j.ygyno.2010.11.033. Epub 2010 Dec 18. Gynecol Oncol. 2011. PMID: 21168904

2

A comparison of laparoscopic radical hysterectomy and pelvic lymphadenectomy and laparotomy in the treatment of Ib-IIa cervical cancer.

Li G, Yan X, Shang H, Wang G, Chen L, Han Y. Li G, et al. Among authors: yan x. Gynecol Oncol. 2007 Apr;105(1):176-80. doi: 10.1016/j.ygyno.2006.11.011. Epub 2007 Jan 2. Gynecol Oncol. 2007. PMID: 17197013

3

Sentinel lymph node detection using methylene blue in patients with early stage cervical cancer.

Yuan SH, Xiong Y, Wei M, Yan XJ, Zhang HZ, Zeng YX, Liang LZ. Yuan SH, et al. Gynecol Oncol. 2007 Jul;106(1):147-52. doi: 10.1016/j.ygyno.2007.03.037. Epub 2007 May 11. Gynecol Oncol. 2007. PMID: 17499345

4

Complications of laparoscopic radical hysterectomy and pelvic lymphadenectomy--experience of 117 patients.

Yan X, Li G, Shang H, Wang G, Chen L, Han Y. Yan X, et al. Int J Gynecol Cancer. 2009 Jul;19(5):963-7. doi: 10.1111/IGC.0b013e3181a79430. Int J Gynecol Cancer. 2009. PMID: 19574793

5

Outcome and prognostic factors of laparoscopic radical hysterectomy and pelvic lymphadenectomy in 148 patients with stage IB1 cervical cancer.

Yan X, Li G, Shang H, Lin F, Yang X, Zheng F. Yan X, et al. Int J Gynecol Cancer. 2012 Feb;22(2):286-90. doi: 10.1097/IGC.0b013e318233d549. Int J Gynecol Cancer. 2012. PMID: 22146764

6

Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer.

Chen L, Liang L, Yan X, Liu N, Gong L, Pan S, Lin F, Zhang Q, Zhao H, Zheng F. Chen L, et al. Among authors: yan x. Int J Gynecol Cancer. 2013 Feb;23(2):256-63. doi: 10.1097/IGC.0b013e31827ad2b8. Int J Gynecol Cancer. 2013. PMID: 23358177

7

Triterpenoids as reversal agents for anticancer drug resistance treatment.

Yan XJ, Gong LH, Zheng FY, Cheng KJ, Chen ZS, Shi Z. Yan XJ, et al. Drug Discov Today. 2014 Apr;19(4):482-8. doi: 10.1016/j.drudis.2013.07.018. Epub 2013 Aug 13. Drug Discov Today. 2014. PMID: 23954181 Review.

8

Piperlongumine induces apoptosis and synergizes with cisplatin or paclitaxel in human ovarian cancer cells.

Gong LH, Chen XX, Wang H, Jiang QW, Pan SS, Qiu JG, Mei XL, Xue YQ, Qin WM, Zheng FY, Shi Z, Yan XJ. Gong LH, et al. Oxid Med Cell Longev. 2014;2014:906804. doi: 10.1155/2014/906804. Epub 2014 May 8. Oxid Med Cell Longev. 2014. PMID: 24895529 Free PMC article.

9

Malignant melanoma of the vagina: A case report and review of the literature.

Chen L, Xiong Y, Wang H, Liang L, Shang H, Yan X. Chen L, et al. Among authors: yan x. Oncol Lett. 2014 Oct;8(4):1585-1588. doi: 10.3892/ol.2014.2357. Epub 2014 Jul 17. Oncol Lett. 2014. PMID: 25202372 Free PMC article.

10

Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752.

Chen X, Gong L, Ou R, Zheng Z, Chen J, Xie F, Huang X, Qiu J, Zhang W, Jiang Q, Yang Y, Zhu H, Shi Z, Yan X. Chen X, et al. Among authors: yan x. Gynecol Oncol. 2016 Mar;140(3):537-44. doi: 10.1016/j.ygyno.2015.12.011. Epub 2015 Dec 15. Gynecol Oncol. 2016. PMID: 26704638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,017 results

Search Page

Filters